Pharmaceuticals
10 AstraZeneca executives
These ten AstraZeneca executives have held CFO, executive vice president, senior vice president and country president roles at AstraZeneca, covering BioPharmaceuticals, the International region, the US, the UK, India, the Nordics and the Middle East and Africa. Readers can learn how AstraZeneca leaders run finance, business units, country organizations and regional commercial operations.
Professionals to explore
01—10Aradhana Sarin
LinkedInExperience: Executive Director and Chief Financial Officer · AstraZeneca
Executive Director and Chief Financial Officer at AstraZeneca since August 2021, listed at the C-Level in Finance & Accounting, and also listed as CFO at AstraZeneca since January 2021. Former CFO at Alexion Pharmaceuticals (2019–2021), before the two current AstraZeneca finance roles listed on the profile.
Bhavana Agrawal
LinkedInExperience: Chief Financial Officer - Middle East & Africa · AstraZeneca
Chief Financial Officer - Middle East & Africa at AstraZeneca since September 2026, listed at the C-Level. Former Executive Director (2024–2026) and Chief Financial Officer - India (2023–2026) at AstraZeneca India, Chief Financial Officer Designate - India (2023), and former CFO services - Emerging Markets at GE HealthCare (2021–2022).
Iskra Reic
LinkedInExperience: EVP, International · AstraZeneca
EVP, International at AstraZeneca since December 2024, a region the profile says includes China, Asian and Eurasian markets, Middle East & Africa, Latin America, Australia and New Zealand. Also listed as EVP, Vaccines & Immune Therapies since 2021, and former EVP, Europe & Canada (2019–2022), EVP, Europe (2017–2019) and Area VP, Russia & Eurasia (2016–2017).
Lars-Johan Cederbrant
LinkedInExperience: Chief Financial Officer Nordics & Sweden, Board member · AstraZeneca
Chief Financial Officer Nordics & Sweden, Board member at AstraZeneca since November 2025. Former Chief Financial Officer AstraZeneca AB Sweden (2022–2025), VP Finance R&D Oncology (2020–2022), Head of Finance CFO, Europe (& International) Oncology (2017–2019) and Global Finance Director CFO, Respiratory Therapy Area (2016–2017) at AstraZeneca.
Mani Sharma
LinkedInExperience: Senior Vice President, Group Controller and Head of Global Finance Services · AstraZeneca
Senior Vice President, Group Controller and Head of Global Finance Services at AstraZeneca since November 2022. Former Senior Vice President, Group Controller and Head of Deal Finance (2020–2022) and Senior Vice President, CFO Global Oncology Business Unit and Head of Deal Finance (2018–2020) at AstraZeneca, and Non Executive Director at an NHS Trust since 2025.
Praveen Rao Akkinepally
LinkedInExperience: Country President & Managing Director · AstraZeneca India
Country President & Managing Director at AstraZeneca India since July 2025. Former Head of Oncology Business Unit, AstraZeneca India (2023–2025), and former Global Head of Lung Cancer Commercialization, Global Marketing (2021–2023), US Head of Marketing, Immuno-Oncology Lung (2019–2021) and US Head of Marketing, Tagrisso & Iressa (2017–2019) at AstraZeneca.
Rick R. Suárez
LinkedInExperience: US President and SVP US BioPharmaceuticals Business Unit · AstraZeneca
US President and SVP US BioPharmaceuticals Business Unit at AstraZeneca since January 2026. Former Country President Spain (2020–2026), Senior Vice President, US Market Access (BioPharma Oncology) and PAP (2018–2020), Vice President, US Market Access (2017–2018) and Executive Director, Managed Markets, National Health Plans (2014–2017) at AstraZeneca.
Ruud Dobber
LinkedInExperience: Executive Vice President and President, BioPharmaceuticals Business Unit · AstraZeneca
Executive Vice President and President, BioPharmaceuticals Business Unit at AstraZeneca since 2019, responsible per the profile for product strategy and commercial delivery across Cardiovascular, Renal & Metabolism, Respiratory and Immunology, and Vaccines & Immune Therapies. Also listed as President, AstraZeneca US and Executive Vice President, North America since 2016, and former Executive Vice President Europe (2013–2016).
Tom Keith-Roach
LinkedInExperience: President, Astrazeneca UK · AstraZeneca
President, AstraZeneca UK since March 2020; the profile describes an overhauled strategy that grew the UK business from 14th in rank. Former Global SVP, Respiratory & Immunology (2015–2020), Global VP, Brilinta (2013–2015), Area VP, Eastern Europe (2010–2013) and President, AstraZeneca Korea (2008–2010).
Umut Ozkul
LinkedInExperience: CFO · AstraZeneca
CFO at AstraZeneca since August 2019, based in Istanbul, with a profile citing more than 20 years in finance and a seat on the management board. Former CFO at Schindler Türkeli Asansör (2018–2019), and former External Affairs Director (2016–2018), CFO - GCC (2015–2016) and CFO - Turkey (2009–2016) at Johnson & Johnson Innovative Medicine.
Choose the right perspective
Match the executive's business unit or country to your question, since a BioPharmaceuticals or International region leader sees different medicines, payers and regulators than a country president or a regional CFO. Check each role's dates to confirm whether the experience you need is current or from an earlier period.
Questions to take into the conversation
- 01How does AstraZeneca decide which therapy areas, launches and markets get more investment?
- 02What do AstraZeneca country and business unit leaders look for when choosing a new commercial, market access or service partner?
- 03How does a global pharmaceutical company balance central portfolio strategy with country-level pricing and access decisions?
Reaching AstraZeneca executives
How can I contact one of these AstraZeneca executives?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 2 companies: AstraZeneca and AstraZeneca India, based on profile data retrieved on October 8, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach AstraZeneca executives?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal